• Medical Professionals
    • Information for Healthcare Providers
    • Clinical Studies
    • Expanded Access
    • Educational Grants
    • Request Information
  • Press Releases
  • Suppliers
  • Skip to main content
  • Skip to footer

Atara Biotherapeutics

  • About
    • Company
    • Management Team
    • Board of Directors
    • Collaborators
  • Technology
  • Pipeline
    • Atara Pipeline
    • Tab-cel®
    • ATA188
    • ATA2271/ATA3271
    • ATA3219
  • Patients & Families
    • Our Mission
    • Stories of Strength
    • About EBV
    • PTLD
    • Multiple Sclerosis
    • Clinical Studies
    • Expanded Access
  • Investors & Media
    • Investors & Media
    • News & Events
    • Financial Results
    • ATRA Stock
    • Analyst Coverage
    • SEC Filings
    • Governance
  • Careers
    • Careers Home
    • Career Areas
    • Tech Ops
    • Job Search
  • Contact
  • Medical Professionals
  • Press Releases
  • Suppliers
  • LinkedIn
  • Twitter
Investors & Media

Investors & Media

  • Investors & Media
  • News & Events
    • Overview
    • Press Releases
    • Events
    • Presentations
    • Email Alerts
    • Investor & Media Contacts
  • Financial Results
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • ATRA Stock
    • Quote
    • Charts
    • Historical Data
    • FAQ
    • Classification Info
  • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Contact The Board
  • News
  • Careers

Events

  • News & Events

  • Overview
  • Press Releases
  • Events
  • Presentations
  • Email Alerts
  • Investor & Media Contacts

Second Quarter 2022 Financial Results Conference Call

Aug 8, 2022 • 4:30 pm EST
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML
  • Email Alerts
  • Contacts
  • RSS News Feed

Footer

  • LinkedIn
  • Twitter
© 2022 Atara Biotherapeutics, Inc. All rights reserved.
  • Privacy Policy
  • Terms of Use
  • Sitemap